ArticleFrontiers in public health2022
Grouping Together to Fight Cancer: The Role of WeChat Groups on the Social Support and Self-Efficacy.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Status and influencing factors of resilience among patients with lung cancer undergoing chemotherapy: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Social media use and depression among middle-aged and older Chinese adults: mediating roles of health literacy and perceived social support.Frontiers in public health · 2026Article
- Online Health-Seeking Behaviors and Information Needs Among Patients With Lymphoma in China: Study of Regional and Temporal Trends.Journal of medical Internet research · 2025Article
- Benefit Finding: The Mediator Linking Social Support to Self - Management Efficacy in Gynecological Cancer.Cancer management and research · 2025Article
- The prognostic role of WeChat-based instant doctor-patient communication in patients with advanced pancreatic cancer.Journal of cancer survivorship : research and practice · 2024Article
- Risk factors of foodborne parasitic diseases still remain in China: a WeChat-based knowledge, attitudes, and practices study.BMC public health · 2024Article
- Information management of full-cycle inpatient bed reservation for cancer patients under the normalised prevention and control of the COVID-19 pandemic.BMC health services research · 2024Article
- Communication Mechanisms and Implications of the COVID-19 Risk Event in Chinese Online Communities.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the increasing number of cancer survivors, the question of how to coexist with cancer has become more and more pressing. This research uses a mutual help WeChat group organized by cancer patients as the research field to observe the daily interactions of cancer patients, so as to improve understanding of how social media technology can help cancer patients in the treatment and recovery process. The study found that the WeChat group is the main source of health knowledge for the participating cancer patients, and that when compared to traditional web-based patient mutual aid communities, the WeChat group is a more timely, popular, continuous, and accurate source of information. Patients in the group can listen and respond to each other's questions and worries, providing both an outlet for patients to vent their emotions and concerns and a source of recognition and encouragement. In addition, this study found that the WeChat mutual aid group improves patients' self-efficacy of disease on four levels: successful experience in curing patients, imitating patients' behavior, verbal persuasion, and emotional support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.